BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27544613)

  • 1. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
    Kiuchi MG; Chen S
    Int J Cardiol; 2016 Nov; 223():494-496. PubMed ID: 27544613
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
    Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
    Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of the renal function after renal sympathetic denervation in refractory hypertensive patients with chronic kidney disease: possible predictors.
    Kiuchi MG; Graciano ML; Chen S; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
    Int J Cardiol; 2015 Nov; 199():10-2. PubMed ID: 26173167
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation.
    Singh RR; McArdle ZM; Iudica M; Easton LK; Booth LC; May CN; Parkington HC; Lombardo P; Head GA; Lambert G; Moritz KM; Schlaich MP; Denton KM
    Hypertension; 2019 Mar; 73(3):718-727. PubMed ID: 30661475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
    Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
    Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal denervation on kidney function in patients with chronic kidney disease.
    Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
    Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sympathetic denervation in patients with hypertension and chronic kidney disease: does improvement in renal function follow blood pressure control?
    Kiuchi MG; Chen S; Andrea BR; Kiuchi T; Carreira MA; Graciano ML; Lugon JR
    J Clin Hypertens (Greenwich); 2014 Nov; 16(11):794-800. PubMed ID: 25293878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal failure after renal sympathetic ablation in a patient with chronic kidney disease--which came first, the chicken or the egg?
    Schneider S; Baumann M; Lefeldt S; Laugwitz KL; Heemann U
    Int J Cardiol; 2013 Sep; 167(6):e177-8. PubMed ID: 23647587
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS
    Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal sympathetic denervation and renal physiology.
    Kalaitzidis RG; Karasavvidou D; Siamopoulos KC
    Curr Clin Pharmacol; 2013 Aug; 8(3):189-96. PubMed ID: 23173964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal nerve ablation for hypertensive patients with chronic kidney disease.
    Papademetriou V; Doumas M; Anyfanti P; Faselis C; Kokkinos P; Tsioufis C
    Curr Vasc Pharmacol; 2014 Jan; 12(1):47-54. PubMed ID: 23905594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
    Hering D; Esler MD; Schlaich MP
    EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?
    de Beus E; de Jager R; Joles JA; Grassi G; Blankestijn PJ
    J Hypertens; 2014 Sep; 32(9):1751-61. PubMed ID: 24805954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
    Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional guided renal denervation: Carrying coals to Newcastle?
    Xiao Y; Dong B; Long D; Zhou S; Liu Q
    Int J Cardiol; 2015; 187():545-6. PubMed ID: 25863299
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Cremers B; Janker J; Link B; Vonend O; Ukena C; Linz D; Schmieder R; Rump LC; Kindermann I; Sobotka PA; Krum H; Scheller B; Schlaich M; Laufs U; Böhm M
    Hypertension; 2012 Aug; 60(2):419-24. PubMed ID: 22733462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.